WSTAM
SPPI

Wilbanks Smith & Thomas Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,000
Closed -$218K – 1394
2018
Q3 		$218K Buy
+13,000
New +$281K 0.01% 374

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wilbanks Smith & Thomas Asset Management's SPPI Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 13,000 shares — an estimated $218K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in SPPI in Q3 2018 and held it in 1 quarter. The position peaked at $218K in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 13,000 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $218K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Spectrum Pharmaceuticals Inc position peaked at $218K in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.